Underdiagnosed COPD
Dr. Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading U.S. medical affairs across asthma and COPD, discusses a recent (Dec 2020) study funded by GSK and co-developed by GSK and CHEST as part of the CHEST “Clinical Perspectives” series evaluating the role of pulmonologists, COPD exacerbations, and the need to improve COPD management and education.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Asthma. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Asthma and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Asthma?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Riju Ray, MD, PhD, Senior Medical Lead at GSK, leading U.S.
- Key Point: medical affairs across asthma and COPD, discusses a recent (Dec 2020) study funded by GSK and co-developed by GSK and CHEST as part of the CHEST “Clinical Perspectives” series e…
- Key Point: Riju Ray is an MD/PhD senior medical lead within the Respiratory team at GSK US medical affairs leading teams across both Asthma and COPD.
- Key Point: He is based out of Research Triangle Park in North Carolina.
- Key Point: Ray was an assistant professor at the University of Pennsylvania in Philadelphia.
Dr. Riju Ray is an MD/PhD senior medical lead within the Respiratory team at GSK US medical affairs leading teams across both Asthma and COPD. He is based out of Research Triangle Park in North Carolina. Prior to joining GSK Dr. Ray was an assistant professor at the University of Pennsylvania in Philadelphia. Dr. Ray has worked in clinical development leading clinical trials and medical affairs for GSK. He has worked across different therapeutic areas spanning Respiratory disease, Oncology, Neuroscience and Auto-immune diseases.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



